Fortum's President a
Fortum's President and CEO Tapio Kuula on sick leave
March 25, 2013 06:02 ET | Fortum
Espoo, Finland, 2013-03-25 11:02 CET (GLOBE NEWSWIRE) -- FORTUM CORPORATION STOCK EXCHANGE RELEASE 25 March 2013 Fortum Corporation's President and CEO Tapio Kuula has been diagnosed with...
Talvivaara Flagging
Talvivaara Flagging notification in accordance with Chapter 9 Section 5 of the Finnish Securities Market Act
March 25, 2013 06:00 ET | Talvivaaran Kaivososakeyhtiö Oyj
Stock Exchange Release Talvivaara Mining Company Plc. 25 March 2013 Flagging notification in accordance with Chapter 9 Section 5 of the Finnish Securities Market...
Talvivaaran Arvopape
Talvivaaran Arvopaperimarkkinalain 9 luvun 5 §:n mukainen liputusilmoitus
March 25, 2013 06:00 ET | Talvivaaran Kaivososakeyhtiö Oyj
Pörssitiedote Talvivaaran Kaivososakeyhtiö Oyj 25.3.2013 Arvopaperimarkkinalain 9 luvun 5 §:n mukainen liputusilmoitus Talvivaaran Kaivososakeyhtiö Oyj ("Talvivaara" tai "Yhtiö") on tänään...
Athena IT-Group: Ind
Athena IT-Group: Indkaldelse til ekstraordinær generalforsamling
March 25, 2013 06:00 ET | Athena IT-Group
Der indkaldes herved til ekstraordinær generalforsamling i Athena IT-Group A/S, CVR nr. 19 56 02 01. onsdag den 17. april 2013 klokken 10.00 Den ekstraordinære generalforsamling afholdes hos...
Nexans announces the
Nexans announces the creation of the 'Nexans Foundation'
March 25, 2013 06:00 ET | Nexans
Please find herewith a press release of Nexans Subject: Nexans announces the creation of the 'Nexans Foundation' Please follow this link for the English news: ...
Sernova Awarded Funding to Optimize Its Sertolin(TM) Local Therapeutic Cell Anti-Rejection Technology for the Treatment of Chronic Diseases
March 25, 2013 06:00 ET | Sernova Corp
LONDON, ONTARIO--(Marketwire - March 25, 2013) - Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE:SVA) a clinical stage company today announced that it has been awarded a third...
Vital Therapies, Inc. Announces Increase in Financing
March 25, 2013 06:00 ET | Vital Therapies
SAN DIEGO, CA--(Marketwire - Mar 25, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver...
Studsvik publishes prospectus and applies for listing of corporate bond on NASDAQ OMX Stockholm
March 25, 2013 06:00 ET | Studsvik AB
On February 19, 2013 Studsvik AB (publ) announced the issue of a senior, unsecured corporate bond of SEK 200 million with a maturity of three years in the Swedish market, with final maturity in March...
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING
March 25, 2013 06:00 ET | Höganäs AB
Shareholders of Höganäs AB (publ) are hereby invited to attend the Annual General Meeting (AGM) to be held at 3 p.m. on Monday 29 April 2013 in HB-Hallen, Bruksgatan, Höganäs, Sweden. The premises...
Studsvik offentliggör prospekt och ansöker om notering av företagsobligation på NASDAQ OMX Stockholm
March 25, 2013 06:00 ET | Studsvik AB
Studsvik AB (publ) offentliggjorde den 19 februari 2013 en emission av en senior, icke-säkerställd företagsobligation om 200 miljoner kronor med en löptid om tre år på den svenska marknaden med ett...